NOTV - Inotiv, Inc.
IEX Last Trade
4.75
-0.020 -0.421%
Share volume: 9,826
Last Updated: Fri 27 Dec 2024 08:30:31 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$4.77
-0.02
-0.42%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
23.22%
1 Month
37.15%
3 Months
207.28%
6 Months
180.64%
1 Year
44.93%
2 Year
4.18%
Key data
Stock price
$4.75
DAY RANGE
$4.38 - $4.86
52 WEEK RANGE
$1.35 - $11.42
52 WEEK CHANGE
$32.29
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Robert Leasure
Region: US
Website: inotivco.com
Employees: 2,100
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: inotivco.com
Employees: 2,100
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Inotiv, Inc. provides drug discovery and development services to pharmaceutical, chemical, and medical device industries. It operates through two segments, Contract Research Services and Research Products. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally.
Recent news